Kelsey Vonderheide, PA1.  Heart Failure—a large number of conditions affecting the structure and function of the heart that make it difficult for the.

Slides:



Advertisements
Similar presentations
How would you explain the smoking paradox. Smokers fair better after an infarction in hospital than non-smokers. This apparently disagrees with the view.
Advertisements

Journal Club Alcohol, Other Drugs, and Health: Current Evidence May–June 2010.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence July-August 2007.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2009.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2011.
Journal Club Alcohol and Health: Current Evidence July–August 2004.
Journal Club Alcohol and Health: Current Evidence January-February 2005.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence November–December 2010.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence May-June 2008.
Uncontrolled Hypertension, Systolic and Diastolic Blood Pressure and Development of Symptomatic Peripheral Arterial Disease in the Women’s Health Study.
OPTIMAL BLOOD PRESSURE LEVELS IN ELDERLY PERSONS IN THE REASONS FOR GEOGRAPHIC AND RACIAL DIFFERENCES IN STROKE (REGARDS) COHORT STUDY Maciej Banach*,
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2012.
Hypertension By Dr. Nagwa Eid Saad Prof. Of Internal Medicine & Family Medicine In Cairo University.
COURAGE: Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Purpose To compare the efficacy of optimal medical therapy (OMT)
Results of Monotherapy in ALLHAT: On-treatment Analyses ALLHAT Outcomes for participants who received no step-up drugs.
HOME AND AMBULATORY BLOOD PRESSURE MONITORING
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial ALLHAT study overview Double-blind, randomized trial to determine whether.
PEACE BNP: Omland, T. et al. J Am Coll Cardiol 2007; 50:205–14 Copyright ©2007 American College of Cardiology Foundation. Restrictions may apply. Prognostic.
The effects of initial and subsequent adiposity status on diabetes mellitus Speaker: Qingtao Meng. MD West China hospital, Chendu, China.
Association between Systolic Blood Pressure and Congestive Heart Failure in Hypertensive Patients Mrs. Sutheera Intajarurnsan Doctor of Public Health Student.
AN ASSESSMENT OF THE PRIMARY PREVENTION CONTROL PROGRAM OF PHC PREVENTIVE CARDIOLOGY CLINIC AMONG PATIENTS AT RISK FOR CVD: A Retrospective Cohort Study.
Systolic hypertension not an isolated problem Michael Weber, MD Professor of Medicine Associate Dean Downstate College of Medicine State University of.
The Relationship Between Renal Function and Cardiac Structure, Function, and Prognosis Following Myocardial Infarction: The VALIANT Echo Study Anil Verma,
P REVALENCE OF I SCHEMIC H EART D ISEASE A MONG U RBAN P OPULATION OF S ILIGURI, W EST B ENGAL Mandal S, Saha J B, Mandal S C, Bhattacharya R N, Chakraborthy.
Aim To determine the effects of a Coversyl- based blood pressure lowering regimen on the risk of recurrent stroke among patients with a history of stroke.
To assess the prognostic value of variability in home-measured blood pressure (BP) and heart rate (HR) in a general population. Objective: Methods: BP.
Association between Systolic Blood Pressure and Congestive Heart Failure Complication among Hypertensive and Diabetic Hypertensive Patients Mrs. Sutheera.
CRDAC Questions June 15, 2005 Antihypertensive drugs, with few exceptions, have no outcome claim in their labeling. This is inconsistent with their approval.
ALLHAT Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial JAMA 2002;288:
Community Outreach to Reduce Disparities in Cardiovascular & Diabetes Morbidity & Mortality in the South Bronx Michael Alderman, MD Michelle Johnson, MD,
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence September–October 2015.
Coffee and Cardiovascular Disease
ALLHAT 6/5/ CARDIOVASCULAR DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED BY BASELINE GLOMERULAR FILTRATION RATE (3 GROUPS by GFR)
Association between Systolic Blood Pressure and Congestive Heart Failure in Hypertensive Patients Mrs. Sutheera Intajarurnsan Doctor of Public Health Student.
Probability and odds Suppose we a frequency distribution for the variable “TB status” The probability of an individual having TB is frequencyRelative.
Perindopril Remodeling in Elderly with Acute Myocardial Infarction PREAMIPREAMI Presented at The European Society of Cardiology Hot Line Session, September.
6/5/ CARDIOVASCULAR DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED BY BASELINE GLOMERULAR FILTRATION RATE (4 GROUPS by GFR) ALLHAT.
Date of download: 5/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: Omega-3 Polyunsaturated Fatty Acids and Cardiovascular.
Date of download: 6/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Mortality and Cardiovascular Events Are Best Predicted.
A Randomized Trial of Intensive versus Standard Blood-Pressure Control The SPRINT Research Group* November 9, /NEJMoa R2 이성곤 /pf. 우종신.
Date of download: 6/3/2016 From: Elevated Plasma Homocysteine Level Is an Independent Predictor of Coronary Heart Disease Events in Patients with Type.
Date of download: 6/18/2016 From: Treatment of Anemia in Patients With Heart Disease: A Systematic Review Ann Intern Med. 2013;159(11): doi: /
Left Ventricular Filling Pressure by Doppler Echocardiography in Patients With End-Stage Renal Disease Angela Y-M Wang, Mei Wang, Christopher W-K Lam,
Date of download: 6/22/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Year in Hypertension J Am Coll Cardiol. 2006;48(8):
Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: Making Sense of Statistics in Clinical Trial Reports:
From: Visit-to-Visit Variability of Blood Pressure and Coronary Heart Disease, Stroke, Heart Failure, and Mortality: A Cohort Study Ann Intern Med. 2015;163(5):
Dr John Cox Diabetes in Primary Care Conference Cork
An analysis of 22,672 patients from the CLARIFY registry
Nephrology Journal Club The SPRINT Trial Parker Gregg
Alcohol, Other Drugs, and Health: Current Evidence July–August 2017
Angiotensin converting enzyme inhibitors / angiotensin receptor blockers and contrast induced nephropathy in patients receiving cardiac catheterization:
The SPRINT Research Group
Blood Pressure and Age in Controlling Hypertension
Health and Human Services National Heart, Lung, and Blood Institute
All-cause mortality by treatment group
Optimal Systolic Blood Pressure Target After SPRINT: Insights from a Network Meta- Analysis of Randomized Trials  Sripal Bangalore, MD, MHA, Bora Toklu,
Copyright © 2007 American Medical Association. All rights reserved.
Heart Rate, Life Expectancy and the Cardiovascular System: Therapeutic Considerations Cardiology 2015;132: DOI: / Fig. 1. Semilogarithmic.
PS Sever, PM Rothwell, SC Howard, JE Dobson, B Dahlöf,
Circ Cardiovasc Qual Outcomes
Systolic Blood Pressure Intervention Trial (SPRINT)
The percentage of subjects with de novo development of renal function impairment (GFR
Progress and Promise in RAAS Blockade
Optimal Systolic Blood Pressure Target After SPRINT: Insights from a Network Meta- Analysis of Randomized Trials  Sripal Bangalore, MD, MHA, Bora Toklu,
Table of Contents Why Do We Treat Hypertension? Recommendation 5
Figure 1 Diagram showing analysis flow of patient selection and treatment allocation of ONTARGET/TRANSCEND. Figure 1 Diagram showing analysis flow of patient.
Volume 76, Issue 10, Pages (November 2009)
An ACCORD BP sub-analysis HR: 1.06; 95%CI: ; P=0.61
Associations between type of MI and incident HF
An ACCORD BP sub-analysis HR: 1.06; 95%CI: ; P=0.61
Presentation transcript:

Kelsey Vonderheide, PA1

 Heart Failure—a large number of conditions affecting the structure and function of the heart that make it difficult for the heart to meet the body’s needs  In the US, 5.7 million people are currently affected by Heart Failure  Heart Failure occurs in 10 of every 1000 people over the age of 65  Approximately every 25 seconds, an American will have a coronary event  Approximately every minute, someone will die of one.

Entered “harm AND heart failure” into Google Scholar Found the HTML of the article at the Journal of the American College of Cardiology website Clicked on “Full Text”

Pulse Pressure and Risk for Myocardial Infarction and Heart Failure in the Elderly

 Determine whether pulse pressure is an independent predictor of the incidence of coronary heart disease, congestive heart failure, and overall mortality among the elderly in a specific community in New Haven, Connecticut  FYI: Pulse Pressure = a measurement of arterial stiffness

 Cohort study of 2,152 individuals age 65+  Exclusion Criteria  History of MI  Possible CHF at baseline  Individuals who did not have BP measurements available  Subjects for whom the cause of death could not be determined for certain  Subjects who died within the first year of follow-up  Three seating SBP and DBP readings were obtained, and the average of the 2 nd and 3 rd were used  Pulse pressure was then calculated as the difference between SBP and DBP  Study participants were assessed over a 10-year follow-up period

 During the 10-year follow-up…  328 CHD events occurred  174 validated MIs  154 CHD deaths with no prior MI  224 CHF events occurred  198 hospitalizations for CHF  24 deaths due to CHF with no prior CHF hospitalization  1,046 deaths from any cause

 For each 10 mmHg increment in Pulse Pressure (after baseline factors were adjusted for), there was…  12% increase in risk for CHD  14% increase in risk for CHF  6% increase in risk for total mortality  Older individuals, unmarried individuals, and those with diabetes or a history of hypertension tended to have higher mean PP

 Pulse pressure is an independent and significant predictor of the incidence of CHD and CHF among the elderly  Independent of MAP, SBP, DBP, and hypertension classification  Pulse pressure magnitude is associated with cardiovascular end points in normotensive individuals and those with isolated systolic hypertension.  This association does not hold true for isolated diastolic hypertension.

 Although there were not specific experimental and cohort groups, the study subjects were randomly chosen from a community in New Haven, Connecticut by obtaining a probability sample.  A probability sample is defined as being any method of sampling that utilizes some form of random selection

 N/A because there were no experimental/ control groups.  However, had there been only 2 distinct groups, the researcher would want the randomization list to be concealed to prevent bias.

 Yes  Patients were grouped according to their baseline pulse pressures

 Yes.  Because people who had a history of MI and/or possible CHF were excluded from the study, we can assume that PP was indeed at least part of the reason for the outcome

 Yes, participants were studied over a 10 year period.  Information was obtained on >99% of the cohort members.  It did not matter if they died during the duration of the study as long as the researchers were able to identify the cause of death.

 This is a cohort study. Therefore relative risk is used to measure the magnitude of association.  CHD Incidence RR= 1.12  CHF Incidence RR= 1.14  Total Mortality RR= 1.06  These RR values were obtained after adjusting for age, gender, and other factors.

Chart indicates that the effect of PP was seen in all individuals except those with diastolic hypertension. Indicates isolated systolic hypertension is not a major mediator in the effect of PP

 Most of the PP effect on CHD risk was actually seen in the group of subjects without hypertension who were not taking medications for high blood pressure.  These results suggest that the use of antihypertensive medications does not change the association between PP and cardiovascular end points.

 To determine the precision of the estimate of association, confidence intervals are used. Confidence intervals spanning a large range, are not as useful as those with a smaller range.  CHD IncidenceRR= 1.12CI (95%)=  CHF IncidenceRR= 1.14CI (95%)=  Total MortalityRR= 1.06CI (95%)=  Values adjusted for age, gender, and other factors

Journal of the American College of Cardiology Dr. John Lucich